London · Delayed Price · Currency is GBP · Price in GBX Convatec Group Company Description
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally.
The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma.
In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes.
Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson’s disease.
The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers.
It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 1978 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 10,910 |
| CEO | Jonathan Mason |
Contact Details
Address: 20 Eastbourne Terrace London, W2 6LG United Kingdom | |
| Phone | 44 11 8952 8100 |
| Website | convatecgroup.com |
Stock Details
| Ticker Symbol | CTEC |
| Exchange | London Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | GB00BD3VFW73 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Jonathan Peter Mason | Chief Executive Officer and Director |
| Fiona Victoria Ryder | Group Financial Controller, Chief Financial Officer and Director |
| Walter Morse | Interim Chief Quality and Operations Officer |
| Dr. Divakar Ramakrishnan Ph.D. | Executive Vice President, Chief Technology Officer and Head of Research and Development |
| James Edward Spencer Kerton | EVice President, General Counsel and Company Secretary |
| Emma Rose | Executive Vice President and Chief People Officer |
| Kjersti Grimsrud Biotechnology, M.Sc. | President and Chief Operating Officer of Infusion Care |
| David Shepherd | Chief Commercial Officer |
| Evelyn Douglas J.D. | Executive Vice President and Chief Strategy and Business Development Officer |
| Bruno Pinheiro | President and Chief Operating Officer of Ostomy Care |